This is the second of a two-part article series about Paralyzed Patients and Stem Cell Therapy. This article has extra importance for us as one of our close family members is paralyzed. However, he does not have MS (Multiple Sclerosis). It’s hoped that the stem cell treatment discussed in this article may have benefits for paralyzed spinal cord injury patients as well. Also of note, the article references some paralyzed MS patients who reportedly have been cured of paralysis due to the stem cell treatment. While we have done our level best to confirm the claims, if interested, you should do your own due diligence before exploring stem cell treatment for you or yours.
In another trial, doctors recruited over 100 patients with relapsing MS symptoms and frequent relapses on normal drug therapy. 55 of the patients received Stem Cells Therapy with the remainder put on the best available drug treatment.
It was clear during the treatment follow up the patients receiving the stem cell treatments had their disabilities improve significantly. They were experiencing fewer and fewer complications. Of all the patients in the trial, only one of the stem cell treatment group experienced a relapse. This compares to nearly 71% of those on the drug treatment.
Over time, only 6% of the stem cell treatment groups experienced treatment failure defined as “disability progression”. Again, this compared favorably to the drug treatment group where 60% experienced disability progression.
In a unique move, 30 of the 55 patients originally allocated to the drug treatment part of the trial were moved over to the stem cell treatment group. Across-the-board, these patients also saw improvements in their MS condition.
No Side Effects
One of the pitfalls of modern medicine is that sometimes the cure is worse than the disease. How many of us have watched commercials on TV where they tout some drug which will cure a migraine, for example; but, the side effects could leave one with liver damage, uncontrolled flatulence, heart palpitations, and potentially death.
It’s important to note, therefore, that none of the patients in the stem cell treatment group suffered any significant side effects. No difficulty breathing. No headaches. No muscle fatigue. Nothing.
Researchers across the globe hailed the studies as “hugely encouraging”. The trial provided the first long-term assessment of stem cell therapy effectiveness with the most aggressive form of MS. Importantly, no patients who received the stem cell therapy showed disease signs a year after having the treatment. Additionally, their level of disability improved significantly. Patients will be followed for five years.
While the trial participants will need to be monitored long-term, initial success of the stem cell therapy to address the most debilitating parts of MS are encouraging. The trial demonstrated that stem cell therapy treatment can be delivered effectively and with acceptable safety to people suffering from the ravages of MS.